Zosano Pharma and Eli Lilly and Company Enter Into

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Zosano Pharma and Eli Lilly and Company Enter Into Exclusive Licensing Agreement for Zosano's ZP-PTH Product Candidate

FREMONT, Calif. and INDIANAPOLIS, Dec. 2, 2014 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Zosano) and Eli Lilly and Company (NYSE: LLY ) today announced that they have entered into an exclusive agreement to develop ZP-PTH, Zosano's proprietary formulation of parathyroid hormone 1-34 (PTH) using Zosano's microneedle patch system for the treatment of osteoporosis patients, globally. Zosano has completed a Phase 2 study of ZP-PTH for the treatment of severe osteoporosis, and plans to conduct Phase 3 development.

Under the terms of the agreement, Zosano has granted Lilly an exclusive worldwide license to commercialize ZP-PTH. Lilly will make an equity investment of up to $15 million in Zosano concurrent with the consummation of Zosano's initial public offering of equity securities, and additionally make payments upon achievement of certain regulatory and sales milestones totaling up to $300 million for regulatory approvals and up to $125 million for sales milestones. Zosano is also eligible to receive double-digit royalties on sales of products in major markets and will receive reimbursement of all manufacturing costs.

Pending successful clinical testing outcomes and regulatory approval of ZP-PTH, Lilly will be responsible for commercialization of the product. Zosano will be responsible for funding and developing the product, including clinical, regulatory and manufacturing scale-up activities. Zosano will also manufacture the product and provide commercial product supply to Lilly.

"The treatment of osteoporosis has advanced significantly in recent years, and if approved Zosano's microneedle patch system could offer a potentially innovative way to deliver this important medicine," said David A. Ricks, President, Lilly Bio-Medicines and Lilly Senior Vice President. "Zosano shares our commitment to making life better for the tens of millions of people with osteoporosis around the world, and we look forward to helping advance this potential innovation to improve the patient's experience."

"We are delighted to have Lilly, a global leader in the field of osteoporosis, as our partner as we advance clinical development of ZP-PTH, one of our lead clinical compounds," stated Vikram Lamba, Chief Executive Officer of Zosano. "The product, if approved, could help patients suffering from osteoporosis to get a room temperature stable PTH patch for self-administration, without the need for a subcutaneous injection."

About Osteoporosis

Osteoporosis is a disease characterized by low bone mass and structural deterioration of bone tissue, which can lead to an increase in bone fractures. It mainly affects adults age 50 and older. The National Osteoporosis Foundation (NOF) estimates that approximately nine million adults in the United States have osteoporosis and more than 43 million have low bone mass, placing them at increased risk for osteoporosis and broken bones. As the United States population above the age of 50 increases, the NOF projects that the incidence of osteoporosis will also increase. A patient has severe osteoporosis when he or she has a T-score ≤-2.5 plus one or more fragility fractures. According to the NOF, approximately 700,000 adults in the United States suffer from severe osteoporosis.

About PTH

Teriparatide has an identical sequence to the 34 N-terminal amino acids (the biologically active region) of the 84-amino acid human parathyroid hormone. Once-daily administration of teriparatide stimulates new bone formation on trabecular and cortical bone surfaces by preferential stimulation of osteoblastic activity over osteoclastic activity.

About Zosano Pharma

Zosano Pharma Corporation is a private biopharmaceutical company and a pioneer in the field of transdermal drug delivery. Zosano is developing products using its proprietary microneedle patch system. Zosano's microneedle patch delivers therapeutic compounds through the skin and provides rapid systemic drug delivery in a convenient, needle–free and pain–free system. Zosano's microneedle patch system has been tested in preclinical and clinical studies that demonstrated its technical feasibility with approximately 30 compounds, and over 30,000 of Zosano's patches have been applied to more than 400 patients in seven Phase 1 clinical studies and one Phase 2 clinical study. Zosano seeks to develop products with significant commercial potential both independently and in collaboration with strategic partners. Learn more at www.zosanopharma.com .

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com .

This press release contains forward-looking statements about ZP-PTH as a potential treatment for severe osteoporosis and reflects Zosano's and Lilly's current beliefs. However, as with any pharmaceutical product, there are substantial risks and uncertainties in the process of development and commercialization.  For further discussion of these and other risks and uncertainties, see Zosano's and Lilly's most recent filings with the United States Securities and Exchange Commission. Neither Zosano nor Lilly undertakes any duty to update forward-looking statements.

Corporate Contact: Vikram Lamba Chief Executive Officer, Zosano Pharma 510-745-1297 Media Contact: For Zosano: Jamie Lacey-Moreira 410-299-3310 For Lilly: Scott MacGregor 317-440-4699

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Chicken Production Rises Amid Meat Market Shifts

Updated Category News Views 187

Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 53

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 221

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 206

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 162

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 117

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 215

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading

Top 5 Most Recently Viewed Articles

Essential Guidance to Avoid Contractor Fraud After Disasters

Updated Category News Views 249

Essential Guidance for Consumers: Preventing Contractor Fraud In times of devastating natural disasters, such as those caused by wildfires, consumers often find themselves in vulnerable positions. High winds and dry conditions can lead to situations where homes, businesses, and even schools suffer severe damage. It’s in these challenging times that the threat of...

Continue Reading
Stefan Vinberg: A Visionary Leader in Sustainable Real Estate

Updated Category News Views 60

Stefan Vinberg Achieves Dual Recognition at Prestigious Awards Stefan Vinberg, the respected CEO of Insig AB, has recently received outstanding recognition by winning two significant accolades at the Business Worldwide Magazine CEO Awards. These notable honors are the 'Sustainable Real Estate Leadership Award' and 'Growth Strategy CEO of the Year - Sweden'. This...

Continue Reading
SIME Diagnostics Unveils Breakthrough in Neonatal Lung Testing

Updated Category News Views 344

Introduction to AI in Neonatal Medicine SIME Diagnostics is transforming neonatal care with its innovative approach to evaluating lung maturity in preterm infants. This UK-based medical technology company has recently completed a significant clinical study aimed at addressing respiratory challenges faced by late-preterm newborns. The findings promise not only to enhance...

Continue Reading
Baxter Intl's Q4 Results: Key Takeaways and Insights

Updated Category News Views 164

Understanding Baxter Intl's Q4 Earnings The recent earnings report from Baxter Intl (NYSE: BAX) provides crucial insights for investors and analysts alike. In the fourth quarter, the company revealed some significant insights into its financial health and market performance, prompting a closer examination of what this means for shareholders. Earnings Performance Overview...

Continue Reading
Morgan Stanley Sheds Light on UK Investment Trends

Updated Category News Views 99

Insights on UK Investment Intentions From Morgan Stanley Recently, UK assets have captured significant attention, prompting Morgan Stanley (NYSE: MS) to conduct a survey aimed at understanding investors' views, intentions, and positions regarding these assets. This survey highlights the current sentiment surrounding investments in the UK amid uncertain market conditions....

Continue Reading